News Search Results
May 25, 2026, 08:45 ET A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 25, 2026, 05:51 ET MGI Tech Secures Three iF Design Awards for Breakthrough in Sequencing and Ultrasound
ultrasound system and genetic sequencer BGISEQ-50 for the unconventional design in refining user experience by smart integration of comprehensive biotechnology. In 2021, MGI was honored iF Design Award for genetic sequencer T7 and benchtop sequencing lab E5, followed by the genetic sequencer G99 and a portable
More news about: MGI Tech Co., Ltd.
May 23, 2026, 09:41 ET ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
844-916-0895ImmunityBio, Inc. (IBRX) Securities Class Action: ImmunityBio is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system
More news about: Hagens Berman Sobol Shapiro LLP
May 22, 2026, 15:35 ET TIPCO Technologies Expands Frederick Hose Center to Support Local Industry Growth
Frederick, MD 21703. The expanded footprint strengthens the company's ability to serve Frederick County's growing construction, manufacturing, and biotechnology sectors with faster service and expanded capabilities.
More news about: TIPCO Technologies
May 22, 2026, 12:13 ET Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
May 22, 2026, 12:06 ET Costa Rica Strengthened Investment Promotion Efforts in Europe Across Agritech, Global Services and Tourism Infrastructure
global stakeholders across agricultural innovation, biotechnology, research and development.During the event, PROCOMER held meetings with international companies exploring opportunities related to agricultural R&D, plant breeding, biotechnology and agritech operations.Costa Rica promoted
More news about: Promotora de Comercio Exterior de Costa Rica (PROCOMER)
May 22, 2026, 10:15 ET Protein Expression Market worth $7.65 billion by 2031 | MarketsandMarkets™
& Insights:By offering, in 2025, the product segment had the largest share of 81.8%.Pharmaceutical & biotechnology companies dominated the the protein expression products market in 2025 with a share of 32.5%.North America accounted for the largest market
More news about: MarketsandMarkets
May 22, 2026, 07:06 ET Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
May 22, 2026, 07:00 ET Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
May 22, 2026, 06:00 ET As Genetics Reshapes Healthcare, SCU Prepares Students for Growing Workforce
Human Genetics and Genomics and Master of Science in Genetic Counseling programs, which train graduates to work across clinical, research, and biotechnology settings where genomic medicine is rapidly expanding.The need is being driven by the expanding use of genetic testing, precision medicine,
More news about: Southern California University of Health Sciences
May 22, 2026, 02:00 ET La Trobe Corridor Opens Australian Pathway for Indian Startups
collaboration expanded global opportunities for India's biotechnology entrepreneurs."Karnataka has played a central role in shaping India's biotechnology ecosystem, with startups driving innovation across healthcare, agriculture and industrial biotechnology. The Bio Innovation Corridor with La Trobe University
More news about: La Trobe University
May 21, 2026, 17:18 ET INVESTOR DEADLINE TUESDAY: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
[email protected] ALLEGATIONS: ImmunityBio is a biotechnology company that focuses on innovating, developing, and commercializing next-generation immunotherapies. According to the complaint, ImmunityBio's lead
More news about: Robbins Geller Rudman & Dowd LLP
May 21, 2026, 17:17 ET Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
Calif., May 21, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the final data from the Phase 3 AcceleRET-Lung clinical trial of GAVRETO®
More news about: Rigel Pharmaceuticals, Inc.
May 21, 2026, 17:00 ET Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
TARRYTOWN, N.Y., May 21, 2026 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today
More news about: Sapience Therapeutics, Inc.
May 21, 2026, 17:00 ET New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
REDMOND, Wash., May 21, 2026 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan), BL-M14D1, T-Bren (BL-M07D1), and BL-M05D1, four distinct
More news about: SystImmune, Inc.
May 21, 2026, 17:00 ET Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 21, 2026, 16:54 ET Positive topline results from the pivotal Phase 3 REDUCE 2 study of pozdeutinurad in gout
submissions."Pozdeutinurad was added to Sobi's global development portfolio in February 2026 following its acquisition of Arthrosi, Inc., a biotechnology company focused on developing treatments for gout, and further enhances Sobi's presence in this area. Pozdeutinurad is being investigated in two
More news about: Swedish Orphan Biotrauma AB
May 21, 2026, 16:51 ET Positive topline results from the pivotal Phase 3 REDUCE 2 study of pozdeutinurad in gout
submissions."Pozdeutinurad was added to Sobi's global development portfolio in February 2026 following its acquisition of Arthrosi, Inc., a biotechnology company focused on developing treatments for gout, and further enhances Sobi's presence in this area. Pozdeutinurad is being investigated in two
More news about: Swedish Orphan Biotrauma AB
May 21, 2026, 16:05 ET Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
PLYMOUTH MEETING, Pa., May 21, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
May 21, 2026, 16:04 ET Maryland Stem Cell Research Commission Announces More Than $12.6 Million in Awards to Advance Regenerative Medicine and Opens Applications for Next Funding Cycle
Therapeutics (Dr. Tea Soon Park), Reprocell USA (Dr. Yongming [LUKE] Ren), NuGate Therapeutics (Dr. Anthony Accorsi) and Lentigen Technology, a Miltenyi Biotechnology Company (Dr. Rimas Orentas).Clinical: These awards support public and private entities conducting human stem cell-based
More news about: Maryland Stem Cell Research Commission
May 21, 2026, 15:10 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
$14 billion. As The Wall Street Journal observed in January 2026, "[f]or context, only 20 of the 261 companies in the Nasdaq Biotechnology Index had a greater market value; the index doesn't include Regencell." At all relevant times, Defendants downplayed the likelihood and severity
More news about: Pomerantz LLP
May 21, 2026, 14:32 ET MGI Tech Showcases Next-Generation Laboratory Automation and Multi-Omics Solutions at SLAS 2026
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech Co., Ltd.
May 21, 2026, 13:33 ET Lysine Market Expands as Precision Animal Nutrition Gains Global Momentum | CAGR 6.4%
relies on microbial fermentation processes using agricultural feedstocks such as corn, wheat, and cassava. Manufacturers are investing heavily in biotechnology innovations to improve yield efficiency, reduce production costs, and enhance operational sustainability.Advanced fermentation strains now
More news about: Persistence Market Research Pvt. Ltd.
May 21, 2026, 13:23 ET New report highlights gap between New GMO hype and global market reality
advancements made by several global communities, often led by indigenous, smallholder farmers, peasant movements and farm workers, in resisting biotechnology in the food system. The report's findings are stark: Despite the hype of new genetic engineering breakthroughs, often driven by the promise of climate
More news about: Non-GMO Project
May 21, 2026, 12:00 ET HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
SEATTLE, May 21, 2026 /PRNewswire/ -- HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington, today announced that it received the Medical CBRN Defense Consortium (MCDC) Innovation Prototype Award. The
More news about: HDT Bio Corp.